Patent details

EP1220923 Title: FACTOR IX/FACTOR IXa ACTIVATING ANTIBODIES

Basic Information

Publication number:
EP1220923
PCT Application Number:
PCT/EP/2000/008936
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009676669
PCT Publication Number:
WO/2001/019992
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FACTOR IX/FACTOR IXa ACTIVATING ANTIBODIES
French Title of Invention:
ANTICORPS D'ACTIVATION DU FACTEUR IX/FACTEUR IXa
German Title of Invention:
FAKTOR IX/FAKTOR IXA AKTIVIERENDE ANTIKÖRPER
SPC Number:

Dates

Filing date:
13/09/2000
Grant date:
27/06/2007
EP Publication Date:
27/06/2007
PCT Publication Date:
22/03/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/07/2002
EP B1 Publication Date:
27/06/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/09/2007
Expiration date:
13/09/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/09/2000
 
 

Name:
Baxter Aktiengesellschaft
Address:
Industriestrasse 67, 1221 Wien, Austria (AT)

Inventor

1

Name:
KERSCHBAUMER Randolf
Address:
Austria (AT)

2

Name:
FALKNER Falko-Guenter
Address:
Austria (AT)

3

Name:
DORNER Friedrich
Address:
Austria (AT)

4

Name:
SCHWARZ Hans, Peter
Address:
Austria (AT)

5

Name:
SCHEIFLINGER Friedrich
Address:
Austria (AT)

Priority

Priority Number:
157699
Priority Date:
14/09/1999
Priority Country:
Austria (AT)

Classification

Main IPC Class:
C12N 15/13;
Filing date Document type Number of pages